AMLX Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 5% planned / 95% discretionary
Largest single sale: $1.9M.
Where they traded
Last open-market purchase: May 21, 2026 , by Firestone Karen .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B 2 fills | Co-Chief Executive Officer | Sell | 30,464 | $32.19 | $980.5K | 3,614,042 −0.8% of holding | |
| Klee Justin B. 2 fills | Co-Chief Executive Officer | Sell | 30,464 | $32.18 | $980.3K | 3,614,495 −0.8% of holding | |
| FRATES JAMES M 2 fills | Chief Financial Officer | Sell | 10,810 | $32.36 | $349.8K | 234,667 −4.4% of holding | |
| Bedrosian Camille L 2 fills | Chief Medical Officer | Sell | 10,028 | $32.40 | $324.9K | 280,145 −3.5% of holding | |
| Mazzariello Gina 2 fills | Chief Legal Officer | Sell | 9,536 | $32.46 | $309.5K | 190,849 −4.8% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell 10b5-1 | 15,000 | $17.61 | $264.1K | 179,090 −7.7% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell 10b5-1 | 15,000 | $18.32 | $274.7K | 194,090 −7.2% of holding | |
| Firestone Karen | Director | Buy | 3,800 | $13.51 | $51.3K | 66,900 | |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 29,282 | $14.48 | $424.1K | 3,334,683 −0.9% of holding | |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 29,282 | $14.47 | $423.8K | 3,334,616 −0.9% of holding | |
| FRATES JAMES M | Chief Financial Officer | Sell | 7,909 | $14.52 | $114.9K | 165,638 −4.6% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell | 6,844 | $14.52 | $99.4K | 134,430 −4.8% of holding | |
| Bedrosian Camille L | Chief Medical Officer | Sell | 6,461 | $14.58 | $94.2K | 169,295 −3.7% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell | 3,419 | $14.14 | $48.4K | 141,274 −2.4% of holding | |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 15,500 | $14.69 | $227.6K | 3,363,898 −0.5% of holding | |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 15,500 | $14.68 | $227.6K | 3,363,965 −0.5% of holding | |
| FRATES JAMES M | Chief Financial Officer | Sell | 3,557 | $14.65 | $52.1K | 173,547 −2% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell | 3,448 | $14.65 | $50.5K | 144,693 −2.3% of holding | |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 1,995 | $13.89 | $27.7K | 3,379,398 −0.1% of holding | |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 1,974 | $13.83 | $27.3K | 3,379,465 −0.1% of holding | |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 136,193 | $13.59 | $1.9M | 3,378,621 −3.9% of holding | |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 136,193 | $13.58 | $1.8M | 3,378,546 −3.9% of holding | |
| Cohen Joshua B | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,632 −0.2% of holding | |
| Klee Justin B. | Co-Chief Executive Officer | Sell | 7,715 | $11.09 | $85.6K | 3,317,586 −0.2% of holding | |
| FRATES JAMES M | Chief Financial Officer | Sell | 3,326 | $11.11 | $37.0K | 177,104 −1.8% of holding | |
| Firestone Karen | Director | Buy | 8,100 | $12.45 | $100.8K | 63,100 | |
| Bedrosian Camille L | Chief Medical Officer | Sell | 6,580 | $14.35 | $94.4K | 175,756 −3.6% of holding | |
| Klee Justin B. 2 fills | Co-Chief Executive Officer | Sell | 29,975 | $14.38 | $431.0K | 3,325,501 −0.9% of holding | |
| Cohen Joshua B 2 fills | Co-Chief Executive Officer | Sell | 29,933 | $14.35 | $429.5K | 3,325,547 −0.9% of holding | |
| Bedrosian Camille L | Chief Medical Officer | Sell | 12,039 | $14.58 | $175.5K | 182,336 −6.2% of holding | |
| FRATES JAMES M | Chief Financial Officer | Sell | 10,558 | $14.65 | $154.7K | 280,430 −3.6% of holding | |
| Mazzariello Gina | Chief Legal Officer | Sell | 8,828 | $14.58 | $128.7K | 148,141 −5.6% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.